NCT00156143已完成3 期
GH Therapy in Partial GHD Adolescents : Evaluation of Efficacy Based on Body Composition and Comparison of 2 Different Doses of Genotonorm®. Open-Label, Randomised, Comparative, Controlled, Parallel-Group, Multi-Center Phase IIIB Clinical Trial.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 90
- 主要终点
- Change from baseline of the % of fat mass assessed by DEXA after 1 year of treatment.
研究概览
简要总结
To evaluate in boys and girls the improvement in body composition under GH treatment in adolescents with CO-GHD who remain partially GHD after GH discontinuation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 20 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males or females : Chronological age > or = 15 years and < or = 20 years for females
- •Chronological age > or = 17 years and < or = 20 years for males
- •GHD of childhood onset treated for at least 2 years
- •Last GH injection at least 12 months before baseline visit
排除标准
- •Turner's syndrome
- •Chronic hepatic impairment as shown by GGT and / or ASAT and / or ALAT > 2 X ULN
结局指标
主要结局
Change from baseline of the % of fat mass assessed by DEXA after 1 year of treatment.
次要结局
未报告次要终点
研究者
相似试验
撤回
不适用
Growth Hormone Use in Adolescents and Adults With Cystic FibrosisCystic FibrosisNCT00287430University of Texas Southwestern Medical Center
已完成
不适用
Consequence of Lifetime Isolated Growth Hormone DeficiencyGrowth Hormone DeficiencyNCT00149708National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)400
已完成
不适用
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone DeficiencyGrowth Hormone DeficiencyAcromegalyPituitary DiseaseNCT00182091Massachusetts General Hospital75
已完成
2 期
Phase II Study of Growth Hormone in Children With Cystic FibrosisCystic FibrosisNCT00016445University of Utah40
已完成
不适用
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly TreatmentAcromegalyNCT01302652Massachusetts General Hospital20
